Advanced Intellectual Property Strategies for Defending Your Life Sciences IPO
The Deal's 2nd half M&A scene: Interview with Spencer Klein, Morrison Foerster
Innovative Exit Strategies for Life Sciences Companies – Interview with Bill Whelan, Member, Mintz Levin
Financing Trends in Life Sciences – Interview with Bill Whelan, Member, Mintz Levin
Polsinelli Podcast - Emerging Technology & Startup Companies
Digital Health: Where is the Action for Entrepreneurs?
Welcome to the December 2014 edition of Red Notice, a publication of Akin Gump Strauss Hauer & Feld LLP.
This month on the anticorruption front, a major cosmetics retailer as well as its subsidiary pleads guilty to...more
In This Issue:
- Here Come the Feds -- What President Obama’s second term means for the tech industry
- Log In:
...Feds cast an eye on social media
...3-D’s IP dimension
We are pleased to provide a collection of commentaries on the critical legal issues facing our clients in 2013.
There is hope that global economic and market conditions will continue to improve despite ongoing...more
Spin-off transactions can be beneficial, but they are complicated, time-consuming and expensive, and can trigger lawsuits and other problems for the parent company if not carefully planned and implemented. This Client Alert...more
Back to Top